International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

MRI Estimation of Liver Iron Concentration in Patients with Hemoglobinopathy in Relation to Serum Ferritin in Basrah

Article Information

Volume / Issue7 / 2 (April-June 2026)
Pages192-205
AccessOpen Access

Publication Timeline

  • Received20 March 2026
  • Accepted18 April 2026
  • Published

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Background: liver iron overload in hemoglobinopathy population with repeated blood transfusion is an important morbidity warranting the evaluation of a non-invasive method of liver iron quantification. MR T2* / R2* relaxometry technique has shown promising results in this domain. 
Aim of Study: this prospective cross sectional study aim to show the value of MR T2*/R2* relaxometry technique, in assessment of hepatic iron overload in a sample of hemoglobinopathy population at our hospital on repeated blood transfusion therapy in South of Iraq (Basra city). 
Patients and Methods: a total of 70 anaemic patients, mean age 21 years  ( range : 1055 years old) patients with hemoglobinopathy who had received repeated blood transfusions and on chelation therapy at time of examination, underwent MRI T2* / R2* relaxometry study. The corresponding iron overload was calculated for each patient, then correlation between MRI relaxometry study and serum ferritin level using correlation coefficient was done. 
Results: at the time of the study, serum ferritin levels ranged between 297 and 7324 ng/l ( mean 1958  ng/l).based on the calculated liver iron concentration (LIC) values show that 37.1% of the patients had moderate level of LIC, the highest prevalence of severe LIC was seen significantly in patients using DFO drug(25%) and in those diagnosed with thalassemia major (16.2%), no significant association between LIC and splenectomy. Strong negative correlation was detected between LIC and T2*, Perfect positive correlation between LIC and R2* and moderate positive correlation between LIC and S. ferritin. No significant correlation between LIC and age.  In conclusion, MRI R2*/T2* provides a non-invasive, precise, and repeatable method for measuring tissue iron content. The treatment of tissue iron excess should be improved by the widespread use of this approach, enabling early chelation intensification & monitoring of iron level & response to treatment 
Conclusion: In conclusion, MRI R2* provides a non-invasive, precise, and repeatable method for measuring hepatic tissue iron content 
Recommendation: that. MRI is effective in management of hemoglobinopathy so,repeat liver MRI for all patients who have LIC > 7mg/g DW liver (every 6 months,or 1year depending on guidelines and Cardiac MRI is required for all patient to exclude cardiac iron deposition.
 

References

  1. Ganz T Systemic iron homeostasis. Physiol Rev. 2013;93(4):1721–41. [Google Scholar][Crossref]
  2. Hershko C, Link G, Cabantchik I. Pathophysiology of iron overload. Ann N Y Acad Sci. 1998;850:191–201. [Google Scholar][Crossref]
  3. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187–93. [Google Scholar][Crossref]
  4. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13(4):399–408. [Google Scholar][Crossref]
  5. Porter JB, Garbowski M. The pathophysiology of transfusional iron overload. Hematol Oncol Clin North Am. 2014;28(4):683–701. [Google Scholar][Crossref]
  6. Hasrat NH, Sawadi NJ, Alhijaj BA, Khalaf AA. Epidemiological characteristics of haemoglobinopathies in Basrah, Iraq: a 10-year study (2013–2022). Int J Med Sci. 2023;6(2):35–40. [Google Scholar][Crossref]
  7. Cabantchik ZI, Breuer W, Zanninelli G, Cianciulli P. LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol. 2005;18(2):277–87. [Google Scholar][Crossref]
  8. Loréal O, Gosriwatana I, Guyader D, et al. Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. J Hepatol. 2000;32(5):727–33. [Google Scholar][Crossref]
  9. Gardenghi S, Marongiu MF, Ramos P, et al. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood. 2007;109(11):5027–35. [Google Scholar][Crossref]
  10. Coates TD, Wood JC. How we manage iron overload in sickle cell patients. Br J Haematol. 2017;177(5):703–16. [Google Scholar][Crossref]
  11. Cappellini MD, Farmakis D, Porter J, et al. MRI for the diagnosis of cardiac and liver iron overload in patients with transfusion-dependent thalassaemia: an algorithm to guide clinical use when availability is limited. Am J Hematol. 2018. doi:10.1002/ajh.25075. [Google Scholar][Crossref]
  12. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology. 2009;49(3):1017– 44. [Google Scholar][Crossref]
  13. Gandon Y, Olivié D, Guyader D, et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet. 2004;363(9406):357–62. [Google Scholar][Crossref]
  14. St Pierre TG, Clark PR, Chua-anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood. 2005;105(2):855–61. [Google Scholar][Crossref]
  15. Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood. 2005;106(4):1460–5. [Google Scholar][Crossref]
  16. Hankins JS, McCarville MB, Loeffler RB, et al. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood. 2009;113(20):4853–5. [Google Scholar][Crossref]
  17. Alexopoulou E, Stripeli F, Baras P, et al. R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients. J Magn Reson Imaging. 2006;23(2):163–70. [Google Scholar][Crossref]
  18. Fahmy ME, Shokeir MHE, Abdel Hady SM, El-Hussiny MA, et al. Evaluation of liver iron concentration in patients with hemoglobinopathy by magnetic resonance imaging. Egypt J Radiol Nucl Med. 2013;44:565–72. [Google Scholar][Crossref]
  19. Anderson LJ. Assessment of iron overload with T2* magnetic resonance imaging. Prog Cardiovasc Dis. 2011;54(3):287–94. [Google Scholar][Crossref]
  20. Pakbaz Z, Fischer R, Fung E, Nielsen P, Harmatz P, et al. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer. 2007;49:329–32. [Google Scholar][Crossref]
  21. Musallam KM, Cappellini MD, Wood JC, GraziaDei G, et al. Elevated liver iron concentration is a marker of increased morbidity in patients with β-thalassemia intermedia. Haematologica. 2011;96:1605–12. [Google Scholar][Crossref]
  22. Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood. 2006;107:3455–62. [Google Scholar][Crossref]
  23. Papakonstantinou O, Alexopoulou E, Economopoulos N, Benekos O, et al. Assessment of iron distribution between liver, spleen, pancreas, bone marrow, and myocardium by R2 relaxometry MRI in patients with beta-thalassemia major. J Magn Reson Imaging. 2009;29:853–9. International Journal of Medical and All Body Health Research www.allmedicaljournal.com [Google Scholar][Crossref]
  24. Angelucci E, Brittenham GM, McLaren CE, Ripalti M, Baronciani D, et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med. 2000;343(5):327–31. [Google Scholar][Crossref]
  25. El Shanshory MR, Awad MA, El Shafey RA, Soliman HH, et al. Evaluation of liver iron concentrations in children with beta thalassemia infected with hepatitis C virus before and after spirulina therapy by MRI. Arch Blood Transfus Disord. 2017;1(1):ABTD.000504. [Google Scholar][Crossref]
  26. Majd Z, Haghpanah S, Ajami GH, et al. Serum ferritin levels correlation with heart and liver MRI and LIC in patients with transfusion-dependent thalassemia. Iran Red Crescent Med J. 2015;17(4):e24959. [Google Scholar][Crossref]
  27. Azarkeivan A, Hashemieh M, Akhlaghpoor S, Shirkavand A, Yaseri M, Sheibani K. Relation between serum ferritin and liver and heart MRI T2* in beta thalassemia major patients. East Mediterr Health J. 2013;19:727–32. [Google Scholar][Crossref]
  28. Kolnagou A, Natsiopoulos K, Kleanthous M, Ioannou A, Kontoghiorghes GJ. Liver iron and serum ferritin levels are misleading for estimating total body iron load in thalassemia patients. Toxicol Mech Methods. 2013;23:48–56. [Google Scholar][Crossref]
  29. Zamani F, Razmjou S, Akhlaghpoor S, Eslami SM, Azarkeivan A, Amiri A. T2* magnetic resonance imaging of the liver in thalassemic patients in Iran. World J Gastroenterol. 2011;17:522–5. [Google Scholar][Crossref]
  30. Assis RA, Kay FU, Rosemberg LA, Parma AH, Nomura CH, Loggetto SR, et al. Iron overload in Brazilian thalassemic patients. Einstein (Sao Paulo). 2011;9:165– 72. [Google Scholar][Crossref]
  31. Eghbali A, Taherahmadi H, Shahbazi M, Bagheri B, Ebrahimi L. Association between serum ferritin level and cardiac and hepatic T2* MRI in patients with major β-thalassemia. Iran J Pediatr Hematol Oncol. 2014;4:17– 21. [Google Scholar][Crossref]
  32. Neufeld EJ. Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood. 2006;107(9):3436–41. [Google Scholar][Crossref]
  33. Kanbour I, Chandra P, Soliman A, De Sanctis V, Nashwan A, Abusamaan S, et al. Severe liver iron concentrations in patients with β-thalassemia major: correlations with serum ferritin and complications. Mediterr J Hematol Infect Dis. 2018;10(1):e2018062. [Google Scholar][Crossref]
  34. Borgna-Pignatti C, Marsella M. Iron deficiency in thalassemia and related disorders. Pediatr Ann. 2008;37(5):329–37. [Google Scholar][Crossref]

How to Cite

Ameer, H. R. A., Mousa, H. J., Badr, F. H., & Alhijaj, B. A. (2026). MRI Estimation of Liver Iron Concentration in Patients with Hemoglobinopathy in Relation to Serum Ferritin in Basrah. International Journal of Medical and All Body Health Research, 7(2), 192-205. https://doi.org/10.54660/IJMBHR.2026.7.2.192-205

Ameer, Huda Riyadh Abdul, et al. "MRI Estimation of Liver Iron Concentration in Patients with Hemoglobinopathy in Relation to Serum Ferritin in Basrah." International Journal of Medical and All Body Health Research, vol. 7, no. 2, 2026, pp. 192-205. https://doi.org/10.54660/IJMBHR.2026.7.2.192-205.

Ameer, H. R. A., Mousa, H. J., Badr, F. H. and Alhijaj, B. A. (2026) 'MRI Estimation of Liver Iron Concentration in Patients with Hemoglobinopathy in Relation to Serum Ferritin in Basrah', International Journal of Medical and All Body Health Research, 7(2), pp. 192-205. doi: 10.54660/IJMBHR.2026.7.2.192-205.

Ameer HRA, Mousa HJ, Badr FH, Alhijaj BA. MRI Estimation of Liver Iron Concentration in Patients with Hemoglobinopathy in Relation to Serum Ferritin in Basrah. International Journal of Medical and All Body Health Research. 2026;7(2):192-205. doi:10.54660/IJMBHR.2026.7.2.192-205

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.